Trial Details

COMPLETED
Basic Information
Clinical ID c395
Identifier NCT04989907
Trial Title A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases|Crohns Disease|Colitis, Ulcerative
Interventions -
Participant Information
Sponsor Takeda
City St. Gallen
Country/Region Switzerland
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2021-09-08
Primary Completion Date 2024-05-17
Completion Date 2024-05-17